Home/Filings/4/0001209191-21-010915
4//SEC Filing

Murphy Eric Anthony 4

Accession 0001209191-21-010915

CIK 0001797768other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 6:03 PM ET

Size

5.4 KB

Accession

0001209191-21-010915

Insider Transaction Report

Form 4
Period: 2021-02-12
Murphy Eric Anthony
Chief Scientific Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-02-12+60,00060,000 total
    Exercise: $35.38Exp: 2031-02-12Common Stock (60,000 underlying)
Footnotes (1)
  • [F1]The Option vests and becomes exercisable over time at the following rate: 1/48th of the total number of shares subject to the Option shall vest each month in equal installments starting on March 1, 2021.

Issuer

Kinnate Biopharma Inc.

CIK 0001797768

Entity typeother

Related Parties

1
  • filerCIK 0001825150

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:03 PM ET
Size
5.4 KB